Research paper accepted in principle (Jan 20, 2021), has been fully accepted for publication in Nature Communications Biology. Luke Thomas, Cinzia Esposito et al and Margaret Ashcroft. Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia.